Ypsomed
Luca Schelbli has work experience as a Medical Device Development Project Lead at Ypsomed AG since October 2020. Prior to this role, they worked as an R&D Engineering at Swiss Wood Solutions from 2017 to 2020. Luca also served as an Intern in Corporate Strategic Projects at Lonza for a few months in 2017. Additionally, Luca worked as a Freelance Journalist at BZ Berner Zeitung from 2010 to 2012.
Luca Schelbli began their education in 2013 at the University of Zurich, where they pursued a Bachelor of Science (B.Sc.) in Chemistry and Business Studies. Luca completed their undergraduate studies in 2016. Following this, Luca Schelbli continued their education at the same university and obtained a Master of Science (M.Sc.) in Chemistry and Business Studies from 2016 to 2018. During their master's program, they also engaged in a Master thesis at ETH Zürich from 2017 to 2018. In 2015, Luca Schelbli briefly studied at Louisiana State University within the same field of study. Moving forward, it appears that Luca Schelbli has future plans to pursue a degree in Portfolio and Project Management in Life Sciences at EPFL (École polytechnique fédérale de Lausanne) in 2023, as mentioned in their education history.
This person is not in the org chart
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.